1. Cancer risk among patients with multiple sclerosis and their parents;Bahmanyar;Neurology,2009
2. Autoimmune comorbid conditions in multiple sclerosis;Berkovich;US Neurol.,2011
3. Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data;Bloomgren;Ther. Clin. Risk Manag.,2012
4. Capkun G., Lahoz R., Chen W., Moore A., Bischof D., Geissbuehler Y., et al., 2014. Comorbidities in patients with multiple sclerosis compared with the general population: retrospective analysis of the US MarketScan Database. Poster presented at the joint European Committee for Treatment and Research in Multiple Sclerosis-Americas Committee for Treatment and Research in Multiple Sclerosis meeting, Boston, USA, 10–13 September 2014, Poster number 179.
5. Medical chart validation of an algorithm for identifying multiple sclerosis relapse in healthcare claims;Chastek;J. Med. Econ.,2010